KNEAT.COM, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4 CAD | -3.15% |
|
+5.82% | +31.15% |
| Feb. 28 | Global Healthcare Leader Selects Kneat | CI |
| Feb. 23 | Kneat.com Maintained at Buy at Stifel GMP After Q4 Results; Price Target Raised to C$4.15 | MT |
Evolution of the average Target Price on kneat.com, inc.
Price target over the last 5 years
History of analyst recommendation changes
5.wO7Pn3XaTxdsLlUMfvi8OumXF6kTYyOYOj5JMrt6lXI.pt34y0Wsfi8_aQ12Dc7KeYLWccFMVVHXaEgaQugf1DSpo6ToRYs6RilPHA~99cf4274a03d2b4b9f2cbeded4f9c40f
More recommendations
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
4
CAD
Average target price
4.358
CAD
Spread / Average Target
+8.96%
High Price Target
5
CAD
Spread / Highest target
+25.00%
Low Price Target
3.7
CAD
Spread / Lowest Target
-7.50%
Consensus detail
Consensus revision (last 18 months)
Analysts covering kneat.com, inc.
| Stifel GMP |
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- KSI Stock
- Consensus kneat.com, inc.